Frontage Holdings Corp
HKEX:1521

Watchlist Manager
Frontage Holdings Corp Logo
Frontage Holdings Corp
HKEX:1521
Watchlist
Price: 1.67 HKD 0.6% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
Frontage Holdings Corp?
Write Note

Frontage Holdings Corp
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Frontage Holdings Corp
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Frontage Holdings Corp
HKEX:1521
Intangible Assets
$37.2m
CAGR 3-Years
36%
CAGR 5-Years
331%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Intangible Assets
$16.3B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
1%
Danaher Corp
NYSE:DHR
Intangible Assets
$19.9B
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Intangible Assets
$262.5m
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Intangible Assets
$547m
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
IQVIA Holdings Inc
NYSE:IQV
Intangible Assets
$4.7B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
32%
No Stocks Found

Frontage Holdings Corp
Glance View

Market Cap
3.4B HKD
Industry
Life Sciences Tools & Services

Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.

Intrinsic Value
2.65 HKD
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Frontage Holdings Corp's Intangible Assets?
Intangible Assets
37.2m USD

Based on the financial report for Dec 31, 2023, Frontage Holdings Corp's Intangible Assets amounts to 37.2m USD.

What is Frontage Holdings Corp's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
331%

Over the last year, the Intangible Assets growth was 11%. The average annual Intangible Assets growth rates for Frontage Holdings Corp have been 36% over the past three years , 331% over the past five years .

Back to Top